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BSTRACT: Over the past decade, sepsis 
has been diagnosed according to consensus 
guidelines established in 1991 as an infection 
in addition to the symptoms of systemic inﬂammatory 
response syndrome (SIRS). In addition to the previous 
criteria, the 2001 conference added several new 
diagnostic criteria for sepsis. Of particular interest was 
the inclusion of the biomarkers procalcitonin (PCT) 
and C-reactive protein (CRP), despite the overall 
conclusion that it was premature to use biomarkers for 
sepsis diagnosis. The primary recommendation of the 
panel was the implementation of the Predisposition, 
insult Infection, Response, and Organ dysfunction 
(PIRO).
The immune system has traditionally been 
devided into innate and adaptive components, each of 
which has a different role and function in defending 
the host against infectious agents. 
Stimulation of different TLRs induces distinct 
patterns of gene expression, which not only leads to 
the activation of innate immunity but also increasing 
evidence supports an additional critical role for TLRs 
in orchestrating the development of adaptive immune 
responses.
The superantigens are able to induce toxic 
shock syndrome and can sometimes cause multiple 
organ failure via adaptive immune system. The 
superantigenic activity of the bacterial exotoxins 
can be attributed to their ability to cross-link major 
histocompatibility complex class II molecules on 
antigen-presenting cells outside the peptide groove 
with T-cell receptors to form a trimolecular complex. 
This trimolecular interaction leads to uncontrolled 
release of a number of proinﬂammatory cytokines. 
Proinﬂammatory cytokines especially IFN-  and TNF-
, the key cytokines causing toxic shock syndrome. 
KEYWORDS: Sepsis • innate immunity • adaptive 
immunity • Toll-like receptors.
Infection and Inflammation
Infection is a term to refer to the existence of various 
germs penetrating to human body. Infection occurs 
when the germs reproduce and cause the damage 
on tissue. Infection will cause injury that creates 
inﬂammation reaction. Although the inﬂammation 
has the same basic process, the intensity and the size 
will be different, depending on the size of the injury 
and reaction of the body. Acute inﬂammation may be 
limited on the place of the injury or may spread that 
cause symptom and systemic phenomenon (1,2).
Inﬂammation is the reaction of vascular tissue 
to all types of injuries. Inﬂammation is a reaction of 
blood vessel, nerves, dilution and body cell on the site 
of injury. Acute inﬂammation is initial direct response 
against the agent causing of injury and most of acute 
inﬂammation related to the production and the release 
of chemical mediator.  
Clinical manifestation of systemic inﬂammation is 
referred as Systemic Inﬂammation Response Syndrome 
(SIRS) (3). It is in accordance to sepsis which is known 
as SIRS with the suspected of infection (4).
DEFINITION
Deﬁnition for sepsis and organ damaged as well as the 
guidance of innovative therapy on sepsis is referred 
to Bone et al (5). Systemic Inﬂammatory Response 
Syndrome is a patient condition who has two or more 
criteria as follows:
1.  Temperature > 38ºC or < 36ºC
2.  Heart beat > 90 / minute
3. Respiration >20/minute or    
Pa CO
2
 < 32 mmHg. 
4. Leukocyte > 12,000/mm3 or > 10% immature 
cell (band).
1Department of Internal Medicine Dr. Moewardi Hospital
2Faculty of Medicine, University of Sebelas Maret, Surakarta
 ͵͵
 Immunopathobiogenesis on SIRS-Sepsis (Hermawan AG)
Indones  Biomed J. 2009; 1(1): 32-9DOI: 10.18585/inabj.v1i1.80
Sepsis is SIRS with identiﬁed of infection 
site (it is determined by the positive culture of 
the organism from the site of infection). Blood 
culture does not have to be positive. Even though 
SIRS, sepsis, and septic shock usually related to 
bacterial infection, there should not be bacteriemia. 
Bacteriemia is the presence of viable bacteria in 
the circulating blood. Bacteriemia usually seen 
after injury on the surface of mucosa, primarily 
without identiﬁed focus of infection, or frequently 
being secondary to intravascular or extravascular 
infection.
Serious sepsis is sepsis that related to organ 
dysfunction, abnormality of hypoperfusion, or 
hypotension. The dysfunction of hypoperfusion 
including (but not limited to):
1. Lactate acidosis
2.  Olyguria
3.  Or acute change on mental status.
Based on international conference on 2001, 
there are more additions to previous criteria. 
Conference of 2001 put several new diagnostic 
criteria for sepsis. The most important part is by 
inserting biomarkers those are procalcitonin (PCT) 
and C - reactive protein (CRP), as the initial step 
in sepsis diagnosis. The main recommendation 
is the implementation system of Predisposition, 
insult Infection, Response, and Organ dysfunction 
(PIRO) to determine the maximum medication 
based on patient characteristic with symptom 
stratiﬁcation and individual risk (6,7).
Figure 1. PIRO - directed Treatment Selection on Patient Characteristics (Adapted from Levy MM, et al.  2003)
INNATE IMMUNITY AND SEPSIS: THE ROLE OF THE 
PATTERN RECOGNITION RECEPTORS (PPRs)
Immune system is traditionally divided into innate immune 
system and adaptive immune system. Each immune 
system has different function and role in protecting host 
from infectious agents. Response of innate immunity is 
programmed as a nonspeciﬁc ﬁrst defense mechanism, 
which acts as a ﬁrst response to eliminate pathogen 
entering the body. To prevent the infectious microorganism 
from entering the body, innate immune system develops 
various receptors, which is known as PRRs, which has the 
capability to recognize speciﬁcally the pattern of molecular 
and pathogen (Pathogen-associated molecular pattern/
PAMPs), so that the innate immune system can distinguish 
the molecule structure of self and non-self ligand (6).  
THE ROLE OF TOLL-LIKE RECEPTOR
Toll-Like Receptors (TRLs) are involved in the host defense 
against the invasion of pathogens. They function as main 
sensor of microbial product and activate the signaling 
path that induced the expression of immune and pro-
inﬂammatory genes. Furthermore, TLRs imply to a number 
of inﬂammation diseases and immune-system-mediated 
diseases. Immune system needs the balance condition 
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TLR have extracellular egion (containing repeated 
leucine) and a cytoplasmic tail, which have a Toll 
domain/Interleukin-1 (IL-1 
will recognize the surface and intracellular component 
Interaction between a TLR and a microbial 
component will activate innate immune system, as 
well as the adaptive immunity development. TLRs 
signaling path begins from TIR-domain, because of 
recruitment of TIR-Domain, which contains adaptor, 
response protein 88), TIRAP (TIR-domain-containing 
adaptor protein), TRIF (TIR- domain-containing 
adaptor protein inducing interferon) and TRAM 
(TRIF-related adaptor molecule).
Signal through each TLR needs Myd88 to produce 
Myd88 will follow the signal through TLR or TLR  
to produce interferon. TRIF is important for signal 
path of TLR  and TLR  that are Myd88-independent, 
of Myd88-independent, which is mediated by TLR . 
TIRAP mediates path of Myd88-Dependent which is 
mediated by TLR  and TLR  ( ).
D 1  A D TLRS
including PRRs (such as D1 ) and the TLRs. D1  
is receptor of glycosylphosphatidylinositol kd that 
role in mediating the response of Lipopolysaccharide 
(LPS). The importance of D1  as a signal transducer 
that related to LPS is a result of a genetic study. 
Ferrero et  al showed mouse expresses excessive D1  
associated with the  hypersensitivity to LPS. n 
protection against LPS that will induce septic shock.
ne of the main progresses in understanding 
the preliminary recognition on microbe and the 
TLRs. According to Medzhitov et  al, TLR  indicates 
the activation of F- K  and induces the expression of 
to LPS. Recently, additional human TLRs have been 
found, and nine TLRs have been characterized. Poltorak 
et  al and ureshi et  al
defect on two mice strains that are hyporesponsive/ 
nonresponsive to LPS associated with TLR . The more 
important thing is they showed a critical information 
on membrane receptor for LPS by recognizing LPS and 
bound to the D1  and transducing the transmembrane 
signal through TLR . 
In the beginning TLR  was associated with the 
signal transducing of LPS, recent genetic studies 
showed that TLR  is the main signal transducer for 
minimum role on LPS signaling, as the mice are 
has indicated that TLR  (rather than TLR ) is receptor 
for positive gram organism (such as Staphylococcus 
aureus and Streptococcus pneumoniae) and its cell 
wall component, bacteria lipoprotein, and fungus 
(1 ).
Superantigen
The immune system against the living or dead bacteria 
 
with related to the induction of gram-negative bacteria 
to the result of the in vitro study. In contrast, in vivo, 
LPS and lymphotoxin alpha (LTA) showed a similar 
released kinetics of T F- .
The pathogenesis of gram-positive bacteria 
depend on the level of production of strong exotoxin. 
Sepsis that is promoted by gram-positive bacteria is 
bacteria fre uently come from skin, wound, soft tissue 
structure, and location of catheter rather than from 
enteric resource or genitourinary. In addition, gram-
positive organism needs a series of response from host, 
with the killing of intracellular by neutrophils and 
pathogen germ, which is ready to be killed in the 
extracellular room by antibody and complement.
xotoxin that is produced by S. aureus and S. 
pyogenes acts as superantigen bacteria, as protein 
molecule that is capable to stimulate the T-cell. 
Superantigen can directly make a bind and stimulate 
the activation of lymphocyte T without attributed 
of macrophages or monocytes as the antigen-
presenting cells (AP s). Superantigen is known to be 
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able to activate up to 20% of body lymphocyte 
and can stimulate the production of various 
inﬂammatory mediator, including IL-2, IFN-  
and colony stimulating factor (CSF) which in turn 
stimulate macrophage (11,12). When macrophage 
is activated, it will secrete not only interleukin-1 
but also a series of enzyme (neutral protease, e.g. 
collagenase and elastase) that is possible to destroy 
the connective tissue, procoagulant molecule 
(tissue factor and factor VII) that can cause local 
coagulation through extrinsic coagulation pathway 
and plasminogen activator. This elastase enzyme 
converts plasminogen into plasmin that will 
damage ﬁbrin and so it will slowly return, and then 
creates coagulation. 
GM-CFS will activate neutrophils and 
components of C-3, C3R, and C5. Neutrophils will 
bind to targeted cell i.e. blood vessel endothelia. 
The function of the blood vessel is then disturbed 
because of the adherence of neutrophils to the 
blood vessel endothelia, followed by the blood 
coagulation due to ﬁbrin deposit. All reactions 
above are called DTH reaction (13). In addition 
to the reaction of DTH, IFN-  can also stimulate 
macrophages to produce IL-1 , IL-6 and TNF- .
These superantigens can also induce toxic shock 
syndrome and cause multi organ failure (MOF) 
without any warning. The activity of bacteria exotoxins 
superantigenic can be linked to its capability to produce 
cross-link with MHC-II molecules  trimolecular complex. 
Each superantigen is recognized link with speciﬁc beta 
domain from T-cell receptor. The interaction of this 
trimolecular functions in controlling the releasing number 
of proinﬂammation cytokines, especially IFN-  and 
TNF- , which are the key cytokines in causing the toxic 
shock syndrome. In addition to those exotoxins harmful 
mechanism, the gram-positive bacteria contain a number 
of immunogenic cell wall components, such as LTA and 
Peptidoglycans (PGNS) (10).
PATHOPHYSIOLOGY OF SEPSIS
Sepsis is not only caused by gram-negative, but also 
by gram-positive that produces exotoxin. Exotoxin, 
virus, and parasite may become superantigens after 
being phagocyted by monocytes or macrophages as 
Antigen Processing Cell. This antigen carries speciﬁc 
polypeptide resulting from Major Histocompatibility 
Complex (MHC). The antigen carrying class II peptide 
MCH will bind to CD4+ (lymphocyte Th1 and Th2) 
under the mediation of TCR (T-Cell Receptor).
Figure 2. Pathophysiology of Sepsis (Adapted from Guntur, 2005)
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As the effort of the body to react against sepsis, 
T lymphocyte will secrete substances from T helper 1 
(TH1) as immuno modulator, i.e. IFN- , IL-2and M-
CSF (Macrophage colony stimulating factor) (12,13). 
Lymphocyte Th2 will express IL-4, IL-5, IL-6 and 
IL-10. IFN-  will stimulate macrophages to secrete 
IL-1  and TNF- . IFN- , IL-1  and TNF-  which 
are proinﬂammatory cytokine, so that on the sepsis 
condition there is an increasing level of IL-1  and 
TNF-  serum. According to several studies, during 
the occurrences of sepsis, the level of IL-1  and TNF-
 correlate with the severity of the disease (4,14). 
However, it appears that cytokine IL-2 and TNF-  
not only a response against sepsis, but also it can 
damage the endothelia of blood vessel of which the 
cause is still unknown (15,16,17). IL-1  as the main 
immuno regulator has also impact the endothelia 
cell, including the formation of prostaglandin E2 
(PG-E2) and stimulate the expression of intercellular 
adhesion molecule-1 (ICAM-1). The presence of ICAM-
1 causes neutrophils, which has been sensitized by 
granulocyte-macrophage colony stimulating factor 
(GM-CSF), more easy to adhere. Interaction between 
endothelia and neutrophyls consist of three steps, i.e.:
1.  The excreted endothelia neutrophyl, P and E-
selectin, and L-selectin binding to the respective 
ligand.
2.  The adherence and activation of neutrophile 
that binds the integrin CD-11 or CD-18, which 
attach neutrophile onto endothelia with 
adhesion molecule secreted by endothelia. This 
step is very important.
3.  The transmigration of neutrophile in penetrating 
the endothelia wall (4,18).
Neutrophyls, which are adhered to endothelia, 
will secrete lysozyme that will cause lysis to the wall of 
endothelia, and make the endothelia open. Neutrophyl 
will also carry superoxidants, which is categorized 
as free radicals that will inﬂuence the oxygenation 
on mitochondria and GMPs cycle. As the result of 
the process, endothelia become necrosis (19), which 
will then cause damage of blood vessel endothelia. 
Apparently, the damage of the endothelial blood 
vessel will cause vascular leak that creates damage 
on multiple organs. This is in accordance with 
Bone’s opinion that the dysfunction of multiple 
organ is not caused by infection, rather than as 
a cause of systemic inflammation with cytokine 
as mediator (20). The argumentation is supported by 
Cohen, who stated that the dysfunction of multiple 
organs is caused by thrombosis and coagulation in 
small blood vessel which in turn cause septic shock 
that ends up in death(15).
Septic shock is clinical diagnosis according to 
sepsis syndrome followed by hypotension (reduced 
blood pressure < 90 mmHg) or reduced systolic 
blood pressure > 40 mmHg from the previous blood 
pressure. The most signiﬁcant organs are liver, 
lungs, and kidney. Mortality rate may increase when 
dysfunction occurs on those three organs. One study 
showed that mortality rate of septic shock is of 72% 
and 50% patients died if they had shock more than 
72 hours, and of 30%–80% patients with septic shock 
suffer Acute Respiratory Distress Syndrome (ARDS) 
(21).
According to Dale DC, patients of diabetes 
mellitus, liver cirrhosis, chronic kidney failure, and 
elderly age that are of group immuno compromised 
(IC) are susceptible to sepsis. Heavy complication 
may frequently occur in IC sepsis patients, such as 
septic shock and end up in death (22,23). To prevent 
the occurrence of continual sepsis, th-2 will express 
IL-10 as antiinﬂammation cytokine that will inhibit 
the expression of IFN- , TNF-  and APC mechanism. 
IL-10 will also repair the damaged tissue caused by 
inﬂammation (24,25). Increasing level of IL-10 give 
the possibility in preventing septic shock in sepsis 
patients.
THE IMPORTANCE OF CYTOKINE IN SEPSIS
We observed 22 patients of sepsis and 5 patients of 
septic shock using cohort method with multivariate 
analysis from seven variable immune responses: 
IL-10, TNF- , IL-1 , IFN- , IgG, C3, C4. There are 
signiﬁcantly different levels between sepsis patients 
and septic shock patients (p<0,05).The study is 
followed by discriminant test to ﬁnd discriminator 
variable (table 1 and 2):
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Table 1. Multivariate test from septic shock and sepsis patients
Septic Shock Sepsis
Variable Average SD Average SD
IL-10 37,268 28,852 15,895 9,002
IFN-γ 11,204 1,557 13,164 11,628
TNF-α 35,640 13,674 19,905 11,927
IL-1β 24,300 45,687 3,491 3,309
IgG 18,632 9,780 14,608 5,611
C3 0,714 0,352 1,662 0,699
C4 26,600 14,293 32,909 13,230
(p<0, 05); n = 27
Table 2. Summary of discriminator variable from septic shock and sepsis data, according to 
the degree of discriminator strenght as shown in Wilks Lambda coefﬁcient.
 
Step Action Entered Variable in Wilks Lambda Sig.
1I L-10 10 ,73000 0,0055
2C 32 0,53434 0,0005
3I gG 30 ,45169 0,0003
4I L-1β 40 ,36799 0,0001
We conclude that the important cytokines in septic 
shock sepsis are IL-1  and IL-10. On the other hands, 
the important i mmune r esponses a re I gG humoral 
response and C
3
 i nnate immune s ystem.  F rom this 
data analysis, we suggested there are many mediators 
from various i mmune s ystems i n sepsis and s eptic 
shock condition. This condition should be understood 
to m ake a  m ore established clinical procedure f or 
sepsis and septic shock.
From this study, it was found that the important 
thing in s epsis i s the balance between I L-1  and I L-
10. If IL-1  is dominant, it will stimulate endothelia to 
increase PGE-2, PAI-1, and I CAM-1. The i ncrease of 
ICAM-1 will attract macrophages and neutrophyl into 
endothelial cells. The adhesive neutrophyl will release 
lysozyms excretion, which damages the cell wall, and 
produces superoxides that damages genes, and lead to 
a death. A series role of IL-1  will cause septic shock 
with DTH (Delayed Type Hypersensitivy) process. 
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If IL-10 is dominant, it will accelerate the maturity 
of B -cell. I t will t hen d ifferentiate t o become plasma 
cell, and produces IgG. IgG has an effective opsonin 
characteristic. Together with phagocyte cell, monocytes 
and macrophage, as well as NK cell will bind tightly 
through Fc receptor, which will then create damage on 
the cell wall of blood vessel with antibody dependent 
cellular cytotoxity (ADCC) process (11). The increase 
of C 3 in t his condition may be t he r esult of t oxin 
activation. C 3 will f orm C3b that c an a ccelerate t he 
heavy ampliﬁcation process from alternative path (it 
is e stimated t hat one deposited C3b in a n organism 
can increase to f our m illions i n four m inutes).  T his 
will i ntensify t he i ncrease of C 3 level. C3 c onsists 
of t wo particles, i .e. C3a and C 3b. C 3a has t he 
characteristic o f anaphylatoxin that c an c ause blood 
vessel dilatation, s o that t he resistance will decrease 
and the permeability of the blood vessel will increase, 
and c ause plasma extravasation. C 3b w ill adhere t o 
targeted c ell wall and f orm unstable bind o f protein 
binding m embrane w ith I gG. It f orms opsonization 
through cell K effector and cause lysis from cell with 
the process of ADCC (26). The result of this process is 
decreasing of blood pressure and shock. The damage 
of blood vessel endothelia is caused not only by DTH, 
but also by ADCC process (11).
Figure 3. Basic Concept of Sepsis (Adapted from Guntur, 2000)
BASIC CONCEPT OF SEPSIS
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